SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad. Amor S, Baker D, Khoury SJ, Schmierer K, et al. Ann Neurol 2020 May 8. doi: 10.1002/ana.25770.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Amor S, Baker D, Khoury SJ, Schmierer K, et al. SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad. Ann Neurol 2020 May 8. doi: 10.1002/ana.25770.
PMID: 32383812